[The desogestrel-ethinyl estradiol combination and overweight: current data]

Area of Science:

• Endocrinology
• Pharmacology
• Reproductive Health

Background:

• Combined oral contraceptives containing progestins and ethinyl estradiol are widely used.
• Previous research has explored their impact on body weight.
• Obesity remains a significant public health concern requiring effective management strategies.

Purpose of the Study:

• To evaluate the effect of desogestrel-ethinyl estradiol on body weight in obese patients.
• To assess the safety and efficacy of this contraceptive in weight management.
• To compare findings with previous studies on similar formulations.

Main Methods:

• A cohort of obese patients was treated with desogestrel-ethinyl estradiol (150 mcg/30 mcg) for weight excess.
• Patient outcomes were monitored under conditions similar to a 1992 study.
• Body weight changes were recorded until patients reached their ideal weight.

Main Results:

• Patients treated with desogestrel-ethinyl estradiol experienced significant body weight loss.
• Weight reduction continued until patients achieved their ideal body weight.
• The contraceptive's efficacy was not negatively impacted by its effect on body weight.

Conclusions:

• Desogestrel-ethinyl estradiol demonstrates a favorable effect on body weight reduction in obese individuals.
• This contraceptive formulation can be a viable option for obese women seeking weight management.
• Further research may explore the mechanisms behind this weight-reducing effect.